SmithKline survives patent loss; The Investment Column

Despite early prognostications of doom, SmithKline Beecham, the drugs giant, has prospered since Tagamet, its blockbuster anti-ulcer drug, went off patent in 1993. As Jan Leschly, the group's well-rewarded chief executive, boasted yesterday, all the numbers are moving in the right direction.

The huge debts taken on in 1994 to buy first Diversified Pharmaceuticals, the US "pharmacy benefit manager" (PBM), and then Sterling Winthrop, a US consumer products group, are being wound down, while earnings growth remains firmly in double figures. Pre-tax profits grew 16 per cent (excluding currency factors and exceptionals) to pounds 1.55bn, while earnings per share jumped by an underlying 14 per cent.

The pound's strength could be a short-term drag, given the proportion of sales on the Continent and the US, but probably not one to lose sleep over. The 14 per cent profits growth to pounds 442m notched up in the fourth quarter would have been a chunky 23 per cent without currency effects, but the group reckons the pound at year-end levels would only have shaved 5 per cent from last year's figures.

It is hard to gauge how successful SmithKline's acquisition record has been, given the opacity of the information on offer. Consumer healthcare trading profits rose a respectable 11 per cent to pounds 372m, and the record on brand growth looks decent. The increased global reach provided by Sterling means that brands such as Aquafresh and Panadol have done well, showing strong growth of 24 and 10 per cent respectively last year. That said, the fall in the first nine months of the over-the-counter version of Tagamet suggests SmithKline's abilities in extending the life of its drugs after patent expiry have taken a while to perfect, although competition has been intense.

The picture is fuzzier at Diversified. The group makes much of the fact that it now "manages" the healthcare requirements of 33 million lives, more than twice the 13.8 million at acquisition, and a drug spend of $5.2bn (pounds 3.2bn). But it refuses to reveal profit figures and in the absence of more concrete evidence, it is hard to avoid the conclusion that the same ends could have been achieved more cheaply by other means.

Acquisitions aside, the record remains good. The pounds 580m rationalisation provision of two years ago has delivered gains of pounds 125m and the core drugs business remains highly successful, growing profits 12 per cent to pounds 1.18bn last year. Sales growth should continue in double digits and the group has no big patent expiries until the next century. Assuming Coreg wins US approval for congestive heart failure later this month, new products, nearly a third of total drug sales, should be performing strongly.

Profits of pounds 1.79bn this year would put the shares, up 13p at 894.5p, on a forward p/e of 21. Hold.

News
peopleHowards' Way actress, and former mistress of Jeffrey Archer, was 60
Sport
Chelsea are interested in loaning out Romelu Lukaku to Everton again next season
sport
News
Robyn Lawley
people
Life and Style
Troy Baker and Ashley Johnson voice the show’s heroes
gamingOnce stilted and melodramatic, Hollywood is giving acting in video games a makeover
PROMOTED VIDEO
News
people
News
i100
Life and Style
Phones will be able to monitor your health, from blood pressure to heart rate, and even book a doctor’s appointment for you
techCould our smartphones soon be diagnosing diseases via Health Kit and Google Fit?
News
people
Extras
indybest
Sport
Usain Bolt confirms he will run in both the heats and the finals of the men's relay at the Commonwealth Games
commonwealth games
Life and Style
tech'World's first man-made leaves' could use photosynthesis to help astronauts breathe
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Senior Investment Accounting Change Manager

£600 - £700 per day + competitive: Orgtel: Senior Investment Accounting Change...

BA/PM,EMIR/Dodd-Frank,London,£450-650P/D

£450 - £650 per day + competitive: Orgtel: My client, a leading bank, is curre...

Senior Analyst - ALM Data - Banking - Halifax

£350 - £400 per day + competitive: Orgtel: Senior Analyst, ALM Data, Halifax, ...

Java developer - Banking - London - Up to £600/day

£500 - £600 per day: Orgtel: Java developer - Banking - London - Up to £600/d...

Day In a Page

Save the tiger: The day America’s love of backyard tigers led to a horrific bloodbath

The day America’s love of backyard tigers led to a horrific bloodbath

With only six per cent of the US population of these amazing big cats held in zoos, the Zanesville incident in 2011 was inevitable
Once stilted and melodramatic, Hollywood is giving acting in video games a makeover

Acting in video games gets a makeover

David Crookes meets two of the genre's most popular voices
Could our smartphones soon be diagnosing diseases via Health Kit and Google Fit?

Could smartphones soon be diagnosing diseases?

Health Kit and Google Fit have been described as "the beginning of a health revolution"
10 best over-ear headphones

Aural pleasure: 10 best over-ear headphones

Listen to your favourite tracks with this selection, offering everything from lambskin earmuffs to stainless steel
Save the tiger: The animals bred for bones on China’s tiger farms

The animals bred for bones on China’s tiger farms

The big cats kept in captivity to perform for paying audiences and then, when dead, their bodies used to fortify wine
A former custard factory, a Midlands bog and a Leeds cemetery all included in top 50 hidden spots in the UK

A former custard factory, a Midlands bog and a Leeds cemetery

Introducing the top 50 hidden spots in Britain
Ebola epidemic: Plagued by fear

Ebola epidemic: Plagued by fear

How a disease that has claimed fewer than 2,000 victims in its history has earned a place in the darkest corner of the public's imagination
Chris Pratt: From 'Parks and Recreation' to 'Guardians of the Galaxy'

From 'Parks and Recreation' to 'Guardians of the Galaxy'

He was homeless in Hawaii when he got his big break. Now the comic actor Chris Pratt is Hollywood's new favourite action star
How live cinema screenings can boost arts audiences

How live cinema screenings can boost arts audiences

Broadcasting plays and exhibitions to cinemas is a sure-fire box office smash
Shipping container hotels: Pop-up hotels filling a niche

Pop-up hotels filling a niche

Spending the night in a shipping container doesn't sound appealing, but these mobile crash pads are popping up at the summer's biggest events
Native American headdresses are not fashion accessories

Feather dust-up

A Canadian festival has banned Native American headwear. Haven't we been here before?
Boris Johnson's war on diesel

Boris Johnson's war on diesel

11m cars here run on diesel. It's seen as a greener alternative to unleaded petrol. So why is London's mayor on a crusade against the black pump?
5 best waterproof cameras

Splash and flash: 5 best waterproof cameras

Don't let water stop you taking snaps with one of these machines that will take you from the sand to meters deep
Louis van Gaal interview: Manchester United manager discusses tactics and rebuilding after the David Moyes era

Louis van Gaal interview

Manchester United manager discusses tactics and rebuilding after the David Moyes era
Will Gore: The goodwill shown by fans towards Alastair Cook will evaporate rapidly if India win the series

Will Gore: Outside Edge

The goodwill shown by fans towards Alastair Cook will evaporate rapidly if India win the series